TIMOTHY HARDIE: Open Payments
NPI 1912499641 · AMERICUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$129 in 7 payments from 7 companies in 2025. Trend: 2023 $40 · 2024 $25 · 2025 $129
Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: QULIPTA, Dexcom G6 Transmitter, JARDIANCE, FANAPT, CAPLYTA, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
